MedTrace Logo

Multicentre Prospective Clinical Trial for RFA Tumour Aspirator Treatment of Primary and Secondary Malignancies of the Liver

NCT00514930 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2007-08-10

No results posted yet for this study

Summary

The primary aim for this trial is to assess whether the RFA aspirator device is safe and of clinical benefit in patients with primary or secondary malignant liver tumours

Conditions

Interventions

DEVICE

Hexablate

Sponsors & Collaborators

  • University of Thessaly

    lead OTHER

Principal Investigators

  • Dimitris Zacharoulis, M.D. · University of Thessaly

  • Nagy Habib, Professor · Imperial College London U.K.

  • Giuseppe Navarra, Professor · University of Messina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Completion
2007-08-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00514930 on ClinicalTrials.gov